All treatments
Treatment
Efanesoctocog alfa clinical trials
2 indexed studies · 1 currently recruiting
- RecruitingPHASE4
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
This study looks at how well a medicine called efanesoctocog alfa works over a long time to keep joints healthy in people with haemophilia A. It aims to understand its real-world benefits in preventing bleeding into joints.
For: Hemophilia ACroatia · Czechia · France - Active not recruitingPHASE3
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
This study is looking at how a new medicine, efanesoctocog alfa, affects physical activity and joint health in people aged 12 and over with severe haemophilia A. Participants will use a special activity tracker and diary.
For: Hemophilia A, SevereAustria · Croatia · Czechia